Charter Medical Introduces Breakthrough Solution For Bio Tech, Pharmaceutical And Cellular Therapy Industries

Main Category: Pharma Industry / Biotech Industry
Article Date: 15 Aug 2008 - 0:00 PDT

email to a friend   printer friendly   opinions  

LYDALL, INC. (NYSE: LDL) Charter Medical Ltd., a subsidiary of Lydall, Inc., has announced a breakthrough Bio-Container that utilizes an innovative new film technology. FREEZE-PAK™ Bio-Containers are designed for use in cryogenic temperature applications providing robust performance as low as -196°C and remain flexible in a frozen state.

FREEZE-PAK™ offers advantages over traditional Bio-Containers as it goes down to the lowest temperature range while also providing easy storage of materials in a pre-sterilized format. They are available in a range of configurations to fit a variety of freezing systems. FREEZE-PAK™ Bio-Containers are designed for maximum product recovery, constructed of animal derivative-free materials and conform to current industry standards.

According to Roberta Morris, Director of Marketing and New Product Development at Charter Medical, "Storage of cellular products is typically performed under cryogenic conditions, with the unique construction of FREEZE-PAK™ a much lower temperature range is achieved compared to typical Bio-Containers which are generally limited to -80°C."

Charter Medical Ltd., a subsidiary of Lydall, Inc., is headquartered in Winston-Salem, North Carolina. Learn more at http://www.chartermedical.com.

Lydall, Inc. is a New York Stock Exchange listed company, headquartered in Manchester, Connecticut. The Company, with operations in the U.S., France, and Germany and sales offices in Europe and Asia, focuses on specialty engineered products for the thermal/acoustical and filtration/separation markets. Charter Medical's Vital Fluid business serves the life science industry with custom-engineered solutions for blood transfusion and medical device applications. Charter Medical manufactures Bio-Pak® single-use Bio-Containers of media, buffers and bulk intermediates in Biotech, Pharmaceutical and Diagnostic reagent manufacturing processes.

Charter Medical Ltd.

• Additional
• References
• Citations